These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2731 related articles for article (PubMed ID: 28094198)
1. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V; Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198 [TBL] [Abstract][Full Text] [Related]
2. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C; Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415 [TBL] [Abstract][Full Text] [Related]
3. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B; Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348 [TBL] [Abstract][Full Text] [Related]
4. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial. Strnad V; Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Fietkau R; Schlamann A; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Dunst J; Gall C; Uter W; Lancet Oncol; 2023 Mar; 24(3):262-272. PubMed ID: 36738756 [TBL] [Abstract][Full Text] [Related]
5. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA; Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635 [TBL] [Abstract][Full Text] [Related]
6. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636 [TBL] [Abstract][Full Text] [Related]
7. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry. Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275 [TBL] [Abstract][Full Text] [Related]
9. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial. King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH; Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696 [TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789 [TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial testing a hyaluronic acid spacer injection for skin toxicity reduction of brachytherapy accelerated partial breast irradiation (APBI): a study protocol. Struik GM; Godart J; Verduijn GM; Kolkman-Deurloo IK; de Vries KC; de Boer R; Koppert LB; Birnie E; Ghandi A; Klem TM; Pignol JP Trials; 2018 Dec; 19(1):689. PubMed ID: 30558672 [TBL] [Abstract][Full Text] [Related]
12. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L; Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience. Kamrava M; Kuske RR; Anderson B; Chen P; Hayes J; Quiet C; Wang PC; Veruttipong D; Snyder M; Jeffrey Demanes D Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S404-11. PubMed ID: 25916980 [TBL] [Abstract][Full Text] [Related]
14. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial. Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302 [TBL] [Abstract][Full Text] [Related]
15. Prospective Comparison of Toxicity and Cosmetic Outcome After Accelerated Partial Breast Irradiation With Conformal External Beam Radiotherapy or Single-Entry Multilumen Intracavitary Brachytherapy. Stecklein SR; Shaitelman SF; Babiera GV; Bedrosian I; Black DM; Ballo MT; Arzu I; Strom EA; Reed VK; Dvorak T; Smith BD; Woodward WA; Hoffman KE; Schlembach PJ; Kirsner SM; Nelson CL; Yang J; Guerra W; Dibaj S; Bloom ES Pract Radiat Oncol; 2019 Jan; 9(1):e4-e13. PubMed ID: 30125673 [TBL] [Abstract][Full Text] [Related]
16. Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method? Roth AM; Kauer-Dorner D; Resch A; Schmid A; Thill M; Niehoff P; Melchert C; Berger D; Kovács G; Brachytherapy; 2014; 13(4):394-9. PubMed ID: 24946973 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of accelerated partial breast irradiation in a large inner-city public hospital. Amin M; Gabram S; Bumpers H; Landry J; Jani AB; Diaz R; Rizzo M Ann Surg Oncol; 2012 Dec; 19(13):4094-8. PubMed ID: 22732836 [TBL] [Abstract][Full Text] [Related]
18. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Veronesi U; Orecchia R; Maisonneuve P; Viale G; Rotmensz N; Sangalli C; Luini A; Veronesi P; Galimberti V; Zurrida S; Leonardi MC; Lazzari R; Cattani F; Gentilini O; Intra M; Caldarella P; Ballardini B Lancet Oncol; 2013 Dec; 14(13):1269-77. PubMed ID: 24225155 [TBL] [Abstract][Full Text] [Related]
19. Partial breast irradiation versus whole breast radiotherapy for early breast cancer. Hickey BE; Lehman M Cochrane Database Syst Rev; 2021 Aug; 8(8):CD007077. PubMed ID: 34459500 [TBL] [Abstract][Full Text] [Related]
20. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy. Berrang TS; Olivotto I; Kim DH; Nichol A; Cho BC; Mohamed IG; Parhar T; Wright JR; Truong P; Tyldesley S; Sussman J; Wai E; Whelan T Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1220-7. PubMed ID: 20971571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]